Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report

Patients who receive solid organ transplants are at higher risk for developing cancer, which is attributable to chronic immune suppression. Less than 8 cases of metastatic RCC (mRCC) have been reported until now. The aim of this article is to present the case of a 77-year-old male with mRCC of the n...

Full description

Bibliographic Details
Main Authors: Daniel Suso-Palau, Julián Chavarriaga, Francisco Usubillaga, Josué Asprilla, Lina Micolta, Marcela Urrego
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Urology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442022000948
_version_ 1818253293521993728
author Daniel Suso-Palau
Julián Chavarriaga
Francisco Usubillaga
Josué Asprilla
Lina Micolta
Marcela Urrego
author_facet Daniel Suso-Palau
Julián Chavarriaga
Francisco Usubillaga
Josué Asprilla
Lina Micolta
Marcela Urrego
author_sort Daniel Suso-Palau
collection DOAJ
description Patients who receive solid organ transplants are at higher risk for developing cancer, which is attributable to chronic immune suppression. Less than 8 cases of metastatic RCC (mRCC) have been reported until now. The aim of this article is to present the case of a 77-year-old male with mRCC of the native kidney and discuss treatment options including targeted therapy, which appears to be the treatment of choice, even in the era of immunotherapy.
first_indexed 2024-12-12T16:37:46Z
format Article
id doaj.art-a9fd0ba75a574e388fcf7d398c7fc9c4
institution Directory Open Access Journal
issn 2214-4420
language English
last_indexed 2024-12-12T16:37:46Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Urology Case Reports
spelling doaj.art-a9fd0ba75a574e388fcf7d398c7fc9c42022-12-22T00:18:38ZengElsevierUrology Case Reports2214-44202022-07-0143102082Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case reportDaniel Suso-Palau0Julián Chavarriaga1Francisco Usubillaga2Josué Asprilla3Lina Micolta4Marcela Urrego5Division of Urology, Clínica Imbanaco – Quirón Salud, Cali, Colombia; Division of Oncology, Clínica Imbanaco – Quirón Salud, Cali, Colombia; Corresponding author. Carrera 38 A No. 5A 100, Cali, 76001, Colombia.Division of Urology, Clínica Imbanaco – Quirón Salud, Cali, ColombiaDivision of Urology, Clínica Imbanaco – Quirón Salud, Cali, ColombiaDivision of Pathology, Clínica Imbanaco – Quirón Salud, Cali, ColombiaDivision of Oncology, Clínica Imbanaco – Quirón Salud, Cali, ColombiaDivision of Oncology, Clínica Imbanaco – Quirón Salud, Cali, ColombiaPatients who receive solid organ transplants are at higher risk for developing cancer, which is attributable to chronic immune suppression. Less than 8 cases of metastatic RCC (mRCC) have been reported until now. The aim of this article is to present the case of a 77-year-old male with mRCC of the native kidney and discuss treatment options including targeted therapy, which appears to be the treatment of choice, even in the era of immunotherapy.http://www.sciencedirect.com/science/article/pii/S2214442022000948MetastasisClear cell renal cell carcinomaTransplantKidney
spellingShingle Daniel Suso-Palau
Julián Chavarriaga
Francisco Usubillaga
Josué Asprilla
Lina Micolta
Marcela Urrego
Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
Urology Case Reports
Metastasis
Clear cell renal cell carcinoma
Transplant
Kidney
title Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_full Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_fullStr Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_full_unstemmed Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_short Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
title_sort metastatic renal cell carcinoma of the native kidney in a renal transplant recipient revisiting the era of tyrosine kinase inhibitors case report
topic Metastasis
Clear cell renal cell carcinoma
Transplant
Kidney
url http://www.sciencedirect.com/science/article/pii/S2214442022000948
work_keys_str_mv AT danielsusopalau metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT julianchavarriaga metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT franciscousubillaga metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT josueasprilla metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT linamicolta metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport
AT marcelaurrego metastaticrenalcellcarcinomaofthenativekidneyinarenaltransplantrecipientrevisitingtheeraoftyrosinekinaseinhibitorscasereport